Monte Rosa Stock Forecast - Accumulation Distribution
| GLUE Stock | USD 8.49 0.14 1.68% |
Monte Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Monte Rosa stock prices and determine the direction of Monte Rosa Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Monte Rosa's historical fundamentals, such as revenue growth or operating cash flow patterns.
Monte |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 43942.41 | 101080.0 |
| Check Monte Rosa Volatility | Backtest Monte Rosa | Trend Details |
Monte Rosa Trading Date Momentum
| On November 18 2024 Monte Rosa Therapeutics was traded for 7.54 at the closing time. The top price for the day was 8.05 and the lowest listed price was 7.47 . The trading volume for the day was 1.4 M. The trading history from November 18, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.58% . The trading delta at closing time against the current closing price is 6.46% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Monte Rosa to competition |
Other Forecasting Options for Monte Rosa
For every potential investor in Monte, whether a beginner or expert, Monte Rosa's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Monte Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Monte. Basic forecasting techniques help filter out the noise by identifying Monte Rosa's price trends.Monte Rosa Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Monte Rosa stock to make a market-neutral strategy. Peer analysis of Monte Rosa could also be used in its relative valuation, which is a method of valuing Monte Rosa by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Monte Rosa Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Monte Rosa's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Monte Rosa's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Monte Rosa Market Strength Events
Market strength indicators help investors to evaluate how Monte Rosa stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Monte Rosa shares will generate the highest return on investment. By undertsting and applying Monte Rosa stock market strength indicators, traders can identify Monte Rosa Therapeutics entry and exit signals to maximize returns.
Monte Rosa Risk Indicators
The analysis of Monte Rosa's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Monte Rosa's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting monte stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.33 | |||
| Semi Deviation | 3.86 | |||
| Standard Deviation | 12.53 | |||
| Variance | 156.97 | |||
| Downside Variance | 21.11 | |||
| Semi Variance | 14.87 | |||
| Expected Short fall | (7.30) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Monte Rosa Therapeutics is a strong investment it is important to analyze Monte Rosa's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Monte Rosa's future performance. For an informed investment choice regarding Monte Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Monte Rosa to cross-verify your projections. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monte Rosa. If investors know Monte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monte Rosa listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.78) | Revenue Per Share 0.221 | Return On Assets (0.28) | Return On Equity (0.61) |
The market value of Monte Rosa Therapeutics is measured differently than its book value, which is the value of Monte that is recorded on the company's balance sheet. Investors also form their own opinion of Monte Rosa's value that differs from its market value or its book value, called intrinsic value, which is Monte Rosa's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monte Rosa's market value can be influenced by many factors that don't directly affect Monte Rosa's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monte Rosa's value and its price as these two are different measures arrived at by different means. Investors typically determine if Monte Rosa is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monte Rosa's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.